In cortical regions of mammalian brain, glial-guided neuronal migration directs postmitotic cells into neuronal layers, a process that underlies the formation of the cortical circuitry ([@r1][@r2]--[@r3]). The cerebellar cortex has long provided a key model for understanding the molecular basis of glial-guided migration, as granule cell precursors (GCPs) migrate from the external germinal layer (EGL) along the radial processes of Bergmann glia (BG) to a position deep to the Purkinje neuron, the sole output neuron of the cerebellar cortex ([@r4]). Correlated video and electron microscopy (EM) imaging of GCP migration along BG demonstrates that migrating neurons form a puncta adherens migration junction beneath the cell soma and extend a motile leading process in the direction of forward movement ([@r5], [@r6]). During migration, the neuron forms and releases the migration junction by a process that involves endocytosis of the receptor astrotactin (ASTN1), which is expressed in neurons but not in glia ([@r7]). Molecular experiments demonstrate that the conserved polarity complex mPar6 regulates the cadence of locomotion by controlling the forward movement of the centrosome ([@r8]) as well as microtubule dynamics and actomyosin motor function in the proximal aspect of the leading process ([@r9]), with the Rho GTPase Cdc42 controlling actin dynamics required for the polarity of the migrating GCP and for the formation of the migration junction with the glial fiber ([@r10]). While biochemical and genetic experiments have confirmed the key role of the neuronal guidance receptor ASTN1 in the migration junction ([@r11][@r12]--[@r13]), evidence is lacking for the glial ligand for ASTN1.

Cadherins are cell-surface proteins composed of an adhesive extracellular domain and a cytoplasmic tail that links to the actin cytoskeleton through a complex of catenins. The extracellular domain allows cadherins to form lateral (*cis*) homodimers or mediate cell adhesion through *trans* homodimers. A large body of evidence demonstrates a key role for homophilic *trans* cadherin interactions in the formation and maintenance of puncta adherens junctions in the developing heart and neural tube ([@r14]) and in synapse formation ([@r15], [@r16]). In addition, disruption of the neural cadherin, N-cadherin (CDH2), leads to defects in neuronal migration during development of the cerebral cortex ([@r17][@r18][@r19][@r20][@r21]--[@r22]). Here we show that an asymmetric *cis* and *trans* complex of ASTN1 and CDH2 functions in neuronal migration. Conditional loss of glial CDH2 in mice impaired GCP migration in vivo and ex vivo and perturbed the formation of a migration junction between GCPs and BG in cell-based assays. Moreover, CDH2-deficient GCPs expressing an ASTN1 variant that lacks the binding domain for CDH2 failed to migrate on CDH2-expressing glia. This suggests that ASTN1 in neurons and CDH2 in neurons and glial fibers form an asymmetric bridge complex that is required for glial-guided migration, and, more generally, that CDH2 might function as a heterophilic binding partner in the formation of other cell--cell junctions.

Results {#s1}
=======

CDH2 Is Expressed in the Migration Junction and Interacts with ASTN1. {#s2}
---------------------------------------------------------------------

To investigate whether CDH2 interacts with ASTN1, we performed immunoprecipitation on protein lysates from postnatal day 7 (P7) mouse cerebella using an ASTN1 antibody. In this assay, we found that ASTN1 interacts with CDH2 ([Fig. 1*A*](#fig01){ref-type="fig"}). We then used Western blotting to examine the developmental expression of CDH2 in the cerebellum. Western blotting of whole-cerebellar lysates showed maximal levels of CDH2 in the early postnatal stages (P4--P10), when ASTN1 expression is high ([Fig. 1*B*](#fig01){ref-type="fig"}). In HEK 293T cells, we detected coimmunoprecipitation of CDH2 with full-length ASTN1 (ASTN1-FL) but not with a mutant variant of ASTN1 lacking a large portion of the C-terminal ectodomain (ASTN1-ΔCTD) that included the membrane attack complex/perforin (MACPF), fibronectin type III (FNIII), and annexin-like (ANX-like) domains ([Fig. 1*C*](#fig01){ref-type="fig"}). Flow cytometry showed that ASTN1-FL and ASTN1-ΔCTD localized to the cell surface at similar levels (58% and 49%, respectively) ([*SI Appendix*, Fig. S1](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)). Thus, the extracellular C terminus of ASTN1 forms a *cis* interaction with the ectodomain of CDH2.

![ASTN1 and CDH2 form *cis* interactions and colocalize in the migration junction. (*A*) In vivo immunoprecipitation of ASTN1 in P7 whole-cerebellar lysates blotted with ASTN1 and CDH2 antibodies. ASTN1 is part of a protein complex with CDH2. (*B*) Developmental protein expression of CDH2 and ASTN1 in the cerebellum of postnatal mice (P1--P28) by Western blot. CDH2 expression was highest between P4--P10, decreased by P16, and reached a steady level at P22--P28. ASTN1 expression increased after P1 and was highest at P7--P10. Protein expression was compared with GAPDH levels. (*C*) Western blots showing coimmunoprecipitation of ASTN1-Venus and CDH2-Myc in HEK 293T cells. CDH2 interacted with ASTN1-FL but not with ASTN1-ΔCTD. (*D* and *E*) Endogenous protein expression of CDH2 at P7 in sagittal mouse cerebellar sections (*D*) and in GCP/BG in vitro cocultures (*E*). CDH2 was expressed in GCPs in the EGL (*D1*), in migrating GCPs in the ML (*D2*), and in Purkinje cells (*D3*) and colocalized with BLBP and GFAP in BG fibers (arrowheads in *D2* and *E*). (*F*--*H*) GCP/BG cocultures labeled with antibodies against CDH2 (*F* and *G*) and ASTN1 (*F* and *H*). CDH2 localized to neuronal processes, glial fibers, and the migration junction beneath the neuronal soma. ASTN1 colocalized with CDH2 in the migration junction (arrows in *F*). PL, Purkinje cell layer. (Scale bars: 50 µm in *D*; 5 µm in *D1*, *D2*, and *F*--*H*; and 10 µm in *D3* and *E*.)](pnas.1811100115fig01){#fig01}

In sections of early postnatal (P5--P7) mouse cerebellum, a CDH2 antibody labeled GCPs in the EGL, GCPs migrating across the molecular layer (ML), and mature granule cells (GCs) in the internal granule layer (IGL) as well as in the radial processes of BG stretching across the ML and in Purkinje cells ([Fig. 1*D*](#fig01){ref-type="fig"}). CDH2 also localized to the migration junction, a puncta adherens junction between migrating GCPs ([@r6]), identified by their elongated profile and close apposition with the glial fiber ([@r5], [@r23]), and BG fibers in cultures of purified neurons and glia ([Fig. 1 *E*--*G*](#fig01){ref-type="fig"}). Antibodies against CDH2 intensely labeled the neuronal soma at the junction with the glial fiber and also stained the underlying glial fiber. In agreement with prior confocal and immuno-EM localization studies ([@r11]), antibodies against ASTN1 labeled the neuronal aspect of the migration junction ([Fig. 1 *F* and *H*](#fig01){ref-type="fig"}). Thus, ASTN1 and CDH2 colocalize to the migration junction of GCPs migrating along BG fibers.

CDH2 and ASTN1 Form Heterophilic *Trans* Interactions. {#s3}
------------------------------------------------------

To analyze whether CDH2 interacts with ASTN1 in *trans* to promote cell adhesion, we used a classical Schneider 2 (S2) cell-adhesion assay ([@r24]). For this assay, we transfected S2 cells with bicistronic expression constructs ([@r25]) of *Cdh2;GFP* or *Astn1;mCherry* cDNA and measured cell aggregation rates over 2 h. Cells transfected with *Cdh2;GFP* formed aggregates within minutes, demonstrating a rapid homophilic *trans* binding of CDH2 ([Fig. 2*A*](#fig02){ref-type="fig"}). In contrast, ASTN1-positive cells did not form homophilic aggregates over the 2-h incubation period. ASTN1-positive cells did, however, form coaggregates with CDH2-positive cells, indicating heterophilic *trans* binding between ASTN1 and CDH2 ([Fig. 2*B*](#fig02){ref-type="fig"}). At 2 h, CDH2-positive aggregates contained 11.7 ± 1.2% ASTN1-positive cells compared with 2.6 ± 0.7% mCherry-expressing control cells (*P* \< 0.0001). Moreover, in contrast to the control cells, ASTN1-positive cells frequently integrated into the core of the aggregates. Taken together, these results confirmed earlier findings that ASTN1 does not promote cell adhesion through homophilic binding ([@r26]) and showed that CDH2 provides a *trans* ligand for ASTN1 that functions in cell--cell adhesion.

![Heterophilic *trans* interactions of ASTN1 and CDH2. *Drosophila* S2 cell-adhesion assays were prepared in four conditions: *Cdh2;GFP* + *mCherry;GFP* (*A*), *Cdh2;GFP* + *Astn1;mCherry* (*B*), *Cdh2;GFP* + *Astn1;mCherry* + ASTN1 Fab (*C*), and *Cdh2-Δ390;GFP* + *Astn1;mCherry* (*D*). ASTN1-positive cells were adhering to the CDH2-expressing aggregates after 30 min (arrows in *B1*), with more coaggregation seen after 1 h (arrows in *B2*) and 2 h (arrows in *B3*), indicating heterophilic *trans* interactions. Significantly lower proportions of cells were adhering to the aggregates in the conditions with cells expressing control vector (*A*) or *Astn1;mCherry* blocked with ASTN1 Fab fragments (*C*). (*D*) Expression of CDH2-Δ390;GFP did not result in cell aggregation within 2 h, demonstrating the importance of the cadherin ectodomain for homophilic and heterophilic interactions and cell adhesion. The proportion of mCherry-expressing cells in the CDH2;GFP-positive aggregates is quantified in *E*. \*\**P* \< 0.01; \*\*\**P* \< 0.001. (Scale bars: 50 µm in *A*--*D* and 10 µm in *Inset* in *B3*.)](pnas.1811100115fig02){#fig02}

To test the specificity of the heterophilic CDH2:ASTN1 *trans* interaction, we measured the aggregation of ASTN1- and CDH2-positive S2 cells in the presence of Fab fragments of an ASTN1 antibody raised against the C terminus of ASTN1 ([@r12]). After addition of Fab fragments, heterophilic CDH2:ASTN1 *trans* cell adhesion was reduced to control levels ([Fig. 2*C*](#fig02){ref-type="fig"}), suggesting that the C terminus of ASTN1 is required for the interaction with CDH2. We then assessed the specificity of both homophilic CDH2:CDH2 and heterophilic CDH2:ASTN1 binding using a *Cdh2-Δ390* construct with a deletion of the extracellular domain of CDH2. In S2 cells expressing CDH2-Δ390, both homophilic adhesion and heterophilic adhesion with ASTN1-positive cells failed ([Fig. 2*D*](#fig02){ref-type="fig"}), demonstrating a requirement for the ectodomain of CDH2 in *trans* cell adhesion.

Cell-Specific Deletion of *Cdh2* in the Cerebellum. {#s4}
---------------------------------------------------

To provide a genetic model for the function of CDH2 in GCP migration in the developing mouse cerebellum, we generated conditional knockout (cKO) of *Cdh2* by crossing a floxed *Cdh2* (*Cdh2*^*fl/fl*^) mouse line with a *NeuroD1-Cre* line to delete *Cdh2* in GCPs. In addition, we crossed the *Cdh2*^*fl/fl*^ mice with an *mGFAP-Cre* line to delete *Cdh2* in BG or with an *hGFAP-Cre* line to delete *Cdh2* in both GCPs and glia ([@r27][@r28]--[@r29]). Western blot analysis of lysates of GCPs and BG purified from each of the lines at P7 ([@r30]) confirmed the cell-specific deletion of *Cdh2* ([*SI Appendix*, Fig. S2*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)). To examine the development of the cerebellum in each of these cKO lines, we first analyzed fixed sections of P7 cerebellum by Nissl staining ([*SI Appendix*, Fig. S2 *B*--*E*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)). Although the overall size of the cerebellum did not differ significantly in the three lines (*n* = 7 per genotype), defects in the foliation pattern of the cerebellum of *Cdh2*^*fl/fl*^*;mGFAP-Cre* and *Cdh2*^*fl/fl*^*;hGFAP-Cre* mice were observed compared with controls. These defects included additional fissures in the ventral (I--III) lobes, with fewer fissures and irregularly shaped lobes in mediodorsal (VI--VIII) areas.

Loss of *Cdh2* in GCs and/or Glia Has a Differential Effect on Migration. {#s5}
-------------------------------------------------------------------------

Immunostaining of cerebellar sections of the three cKO lines with NeuN, a marker for GCs, and with BLBP, a marker for BG, revealed striking differences in GCP migration and formation of the neuronal layers, especially in lines where BG or both BG and GCPs lacked *Cdh2* ([Fig. 3](#fig03){ref-type="fig"}). In all three lines, the density and organization of NeuN-positive GCPs in the inner EGL were identical to that seen in control mice (*n* = 7 per genotype). In *Cdh2*^*fl/fl*^*;NeuroD1-Cre* mice, the elongated profile of GCPs migrating across the molecular layer was indistinguishable from controls, and the overall laminar organization of the cerebellum appeared to be normal ([Fig. 3 *A*--*C*](#fig03){ref-type="fig"}). In contrast, NeuN-positive GCPs had a significantly higher proportion of rounded soma relative to elongated soma in the ML of both *Cdh2*^*fl/fl*^*;mGFAP-Cre* (control: 9.6 ± 0.6%, cKO: 72 ± 13%; *P* = 0.0026) and *Cdh2*^*fl/fl*^*;hGFAP-Cre* (control: 9.5 ± 1.7%, cKO: 79 ± 6.5%; *P* = 0.0014) mice, and many GCPs were located in the ML, suggesting slowed or stalled GCP migration ([Fig. 3 *D*--*I*](#fig03){ref-type="fig"}) ([@r31]). Immunostaining for BLBP in these mice also revealed defects in positioning of BG cell bodies and radial patterning of BG fibers in some areas of the cerebellum ([Fig. 3 *E* and *H*](#fig03){ref-type="fig"}). Overall, the laminar patterning of the cerebellum was disorganized, as the classic boundaries of the ML and IGL were uneven relative to controls. In contrast, immunostaining with a calbindin antibody showed no changes in the gross morphology or positioning of Purkinje cells ([*SI Appendix*, Fig. S3](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)). Thus, a conditional loss of *Cdh2* in BG perturbed the migration of GCPs and the formation of the GC layer.

![Neuronal migration in *Cdh2*-cKO mice. Sagittal cerebellar sections of P7 *Cdh2*^*fl/fl*^ control mice (*A*, *D*, and *G*) and *Cdh2*-cKO littermates expressing *NeuroD1-Cre* (*B*), *mGFAP-Cre* (*E*), or *hGFAP-Cre* (*H*) and labeled with NeuN and BLBP antibodies. In control mice, NeuN-positive GCPs displayed elongated somas along BG fibers in the ML, indicating migrating cells. A similar phenotype is seen in mice with GCPs lacking *Cdh2* (*B*). In contrast, a loss of *Cdh2* in BG (*E*) or in both GCPs and BG (*H*) resulted in rounded GCPs and a stalled migration in the ML. The proportion of elongated and rounded GCPs in the ML is shown in stacked bar charts (*C*, *F*, and *I*). Abnormal radial patterning of BG fibers was observed in some areas (arrowheads in *E*). Higher magnifications in *A′*, *B′*, *D′*, *E′*, *G′*, and *H′* show representative GCPs from each genotype. PL, Purkinje cell layer. \*\**P* \< 0.01. (Scale bars: 50 µm in *A*, *B*, *D*, *E*, *G*, and *H* and 5 µm in *A′*, *B′*, *D′*, *E′*, *G′*, and *H′*.)](pnas.1811100115fig03){#fig03}

To quantitate the rate of GCP migration along BG fibers, we performed BrdU birth-dating experiments, injecting BrdU at P5 and killing the animals at P7 (*n* = 4 per genotype; [*SI Appendix*, Fig. S4 *A*--*I*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)). By BrdU labeling, the migration distance of GCs was reduced in *Cdh2*^*fl/fl*^*;NeuroD1-Cre* mice, in which 40 ± 3.7% of labeled GCs reached the IGL compared with 50 ± 3.9% in control mice (*P* = 0.035). However, GCP migration was dramatically reduced in the *Cdh2*^*fl/fl*^*;mGFAP-Cre* mice, in which 33 ± 4.4% reached the IGL compared with 60 ± 1.9% in control mice (*P* = 0.040). Similarly, in the *Cdh2*^*fl/fl*^*;hGFAP-Cre* mice, 29 ± 2.9% of GCs reached the IGL compared with 55 ± 4.4% in control mice (*P* = 0.0002). The latter two lines also had a significantly higher proportion of BrdU-labeled cells in the ML (22% and 21% higher than in control littermates, *P* = 0.02 and 0.0002, respectively). These findings suggest that the expression of CDH2 in BG fibers is required for GCP migration.

Since a decrease in the number of GCs reaching the IGL could also be due to changes in cell proliferation or cell death, we stained sections with antibodies to the mitosis marker phospho-histone H3 and the apoptosis marker caspase-3. We found no differences in proliferation or apoptosis in the three cKO lines ([*SI Appendix*, Fig. S4 *J* and *K*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)), suggesting that the lower proportion of cells in the IGL resulted from migration defects.

Glial CDH2 Is Essential for GC Migration in Organotypic Slice Cultures. {#s6}
-----------------------------------------------------------------------

To analyze the features of migrating GCPs in the three cKO lines in more detail, we used electroporation to express the fluorophore Venus in GCPs in P8 organotypic slices of cerebellar cortex and imaged labeled cells by spinning-disk confocal microscopy ([Fig. 4](#fig04){ref-type="fig"}). In control slices, after 60 h, Venus-positive GCs were observed in the inner EGL, the ML, and the outer portion of the IGL. Venus-positive cells in the inner EGL extended long parallel fiber axons, with labeled cells in the ML showing the bipolar morphology typical of migrating neurons with a leading process in the radial plane ([Fig. 4 *A*, *D*, and *G*](#fig04){ref-type="fig"}). Although the polarity and overall morphology of labeled GCPs in ex vivo slices of *Cdh2*^*fl/fl*^*;NeuroD1-Cre* cerebellum were similar to controls ([Fig. 4 *A* and *B*](#fig04){ref-type="fig"}), the median distance of migration, calculated by measuring the distance of the cell soma to the parallel fiber axons, was reduced by 37% compared with controls (control: 120 µm, cKO: 75 µm; *P* \< 0.001), indicating a slowed migration rate ([Fig. 4*C*](#fig04){ref-type="fig"}).

![Glial CDH2 is essential for glial-guided neuronal migration. Organotypic ex vivo slice cultures prepared from the cerebellum of P8 *Cdh2*^*fl/fl*^ control and *Cdh2*-cKO mice, electroporated with *Venus*, and fixed after 60 h. In slice cultures from control mice (*A*, *D*, and *G*) Venus-expressing GCPs migrated radially across the ML and extended a leading process in the direction of migration. Although most Venus-positive GCPs lacking *Cdh2* extended a leading process (*B*), their median migration distance was reduced by 37% (*C*). In ex vivo slices where BG lacked *Cdh2* (*E*), or where both GCPs and BG lacked *Cdh2* (*H*), Venus-positive GCPs had a rounded or multipolar morphology, failed to extend a leading process, and migrated a shorter distance away from the field of labeled parallel fibers into the ML, indicating a stalled migration. Dotted lines indicate the ML/IGL boundary. (*A′*, *B′*, *D′*, *E′*, *G′*, and *H′*) Representative cell morphologies are shown at higher magnification. (*F* and *I*) The median migration distance was reduced by 66% (BG cKO) (*F*) and 76% (GCP + BG cKO) (*I*). \*\*\**P* \< 0.001. (Scale bars: 50 µm in *A*, *B*, *D*, *E*, *G*, and *H* and 10 µm in *A′*, *B′*, *D′*, *E′*, *G′*, and *H′*.)](pnas.1811100115fig04){#fig04}

While Venus-positive GCPs in ex vivo organotypic cultures of both *Cdh2*^*fl/fl*^*;mGFAP-Cre* and *Cdh2*^*fl/fl*^*;hGFAP-Cre* mice appeared to extend parallel fiber axons normally, the GCPs had dramatic morphological defects, as nearly all the cells were rounded or irregularly shaped, rather than elongated, and failed to extend a leading process in the direction of migration ([Fig. 4 *E* and *H*](#fig04){ref-type="fig"}). Consequently, the median migration distance was severely reduced in the *Cdh2*^*fl/fl*^*;mGFAP-Cre* (control: 111 µm, cKO: 38 µm; 66% reduction; *P* \< 0.001) and *Cdh2*^*fl/fl*^*;hGFAP-Cre* (control: 109 µm, cKO: 26 µm; 76% reduction; *P* \< 0.001) organotypic cultures ([Fig. 4 *F* and *I*](#fig04){ref-type="fig"}). Importantly, virtually all the Venus-positive cells were stalled in the EGL or the upper portion of the ML, indicating a failure of glial-guided GCP migration.

Functional Interaction of CDH2 and ASTN1 During GC Migration. {#s7}
-------------------------------------------------------------

Since glial, but not neuronal, loss of *Cdh2* stalled GCP migration, we hypothesized that ASTN1 may promote glial-guided migration in the absence of neuronal CDH2. To examine the function of ASTN1 in GCPs positive or negative for CDH2, we electroporated the *Venus*, *Astn1-FL-Venus*, or *Astn1-ΔCTD-Venus* plasmids into cerebella of P8 control and *Cdh2*^*fl/fl*^*;NeuroD1-Cre* mice before generating organotypic cultures. No significant differences in migration distance or proportion of migrating cells were observed between slice cultures with GCPs expressing *Venus* and *Astn1-FL-Venus* ([Fig. 5 *A*, *B*, *D*, and *E*](#fig05){ref-type="fig"}), indicating that ASTN1-FL overexpression did not alter glial-guided migration. However, expression of the *Astn1-ΔCTD-Venus* plasmid in GCPs in control slices reduced the median migration distance by 35% compared with control slices expressing *Venus* (78 µm and 120 µm, respectively; *P* \< 0.001) ([Fig. 5 *C* and *G*](#fig05){ref-type="fig"}), which is similar to the reduction in the *Cdh2*^*fl/fl*^*;NeuroD1-Cre* slices expressing *Venus* ([Fig. 5*G*](#fig05){ref-type="fig"}). This indicates that the ASTN1-ΔCTD protein acted as a dominant-negative variant of ASTN1-FL. Expression of *Astn1-ΔCTD-Venus* in GCPs lacking *Cdh2* (*Cdh2*^*fl/fl*^*;NeuroD1-Cre*) further reduced migration distance by 39% compared with the controls with *Astn1-ΔCTD-Venus* (48 µm and 78 µm, respectively; *P* \< 0.001) and by 60% compared with the controls with *Venus* (48 µm and 120 µm, respectively; *P* \< 0.001) ([Fig. 5 *F* and *G*](#fig05){ref-type="fig"}). Importantly, combined disruption of CDH2 and ASTN1 in GCPs resulted in a significant failure to migrate out of the EGL. In addition, expression of *Astn1-ΔCTD-Venus* in GCPs generated a lower proportion of migrating cells, as characterized by their morphology (rounded/multipolar vs. bipolar) ([Fig. 5*H*](#fig05){ref-type="fig"}). These experiments show that CDH2-deficient GCPs that expressed ASTN1 lacking the domains that bind CDH2 failed to extend a leading process and to migrate. Thus, although homophilic CDH2:CDH2 interactions may contribute to neuron--glial binding, these data demonstrate that heterophilic ASTN1:CDH2 binding is required for glial-guided neuronal migration.

![ASTN1 and CDH2 interact functionally to regulate migration. Organotypic slice cultures from the cerebellum of P8 *Cdh2*^*fl/fl*^ and *Cdh2*^*fl/fl*^*;NeuroD1-Cre* mice were electroporated with *Venus* (*A* and *D*), *Astn1-FL-Venus* (*B* and *E*), or *Astn1-ΔCTD-Venus* (*C* and *F*). ASTN1-Venus fluorescence labeled the cell soma and processes but not the parallel fibers. After 60 h, the distance migrated by GCPs expressing *Astn1-FL-Venus* was similar to that of GCPs expressing *Venus* (*A*, *B*, and *G*) both in the presence and absence of neuronal *Cdh2* (*D*, *E*, and *G*). However, in slice cultures of control mice where GCPs expressed *Astn1-ΔCTD-Venus*, GCPs migrated a 35% shorter distance (78 µm median) than GCPs expressing *Venus* (120 µm median) (*C* and *G*). Loss of *Cdh2* combined with overexpression of *Astn1-ΔCTD-Venus* in GCPs resulted in more severe migration defects, indicated by a 60% reduction in the median migration distance (48 µm) and a higher number of cells stalled in the EGL (*F* and *G*). (*H*) A significantly higher proportion of cells expressing *Astn1-ΔCTD-Venus* were rounded or multipolar. Dotted lines indicate EGL/ML and ML/IGL boundaries. \*\**P* \< 0.01; \*\*\**P* \< 0.001; ns, not significant. (Scale bars: 50 µm in *A*--*F*; 10 µm in *B′*, *C′*, *E′*, and *F′*.)](pnas.1811100115fig05){#fig05}

Neuron--Glia Attachment Is Dependent on Glial Expression of CDH2. {#s8}
-----------------------------------------------------------------

To directly analyze the formation of the migration junction in GCPs and BG lacking *Cdh2*, we generated in vitro chimeras ([@r23], [@r31]). For these experiments, we purified GCPs or BG using a step gradient of Percoll ([@r30]) and mixed and matched GCPs and BG from *Cdh2*^*fl/fl*^ control and *Cdh2*^*fl/fl*^*;hGFAP-Cre* (GCP + BG-cKO) cerebella. Purified GCPs from each genotype were electroporated with either a *Venus* plasmid to visualize the GCP soma and processes or an *Astn1-FL-Venus* plasmid to examine the ASTN1 protein localization and were cocultured with purified glia from each genotype. In control cultures of wild-type GCPs and BG, Venus- or ASTN1-FL-Venus--expressing GCPs adhered to GFAP-labeled BG fibers, formed an elongated profile along the fiber, and extended a leading process in the direction of migration ([Fig. 6 *A* and *B*](#fig06){ref-type="fig"}). ASTN1-FL-Venus localized to the migration junction, and the overexpression did not disrupt neuron--glia attachment or migration. Similar results were observed in cocultures of GCPs lacking CDH2 with control BG ([Fig. 6 *C* and *D*](#fig06){ref-type="fig"}). A strikingly different result was seen when either control or CDH2-deficient GCPs were cultured with BG lacking CDH2. In both cases, although the ASTN1 protein localized to the basal portion of the soma, the neurons failed to form a migration junction ([Fig. 6 *E*--*H*](#fig06){ref-type="fig"}). Measurement of the distance between the GCP soma and BG fiber confirmed this observation ([Fig. 6*I*](#fig06){ref-type="fig"}). In addition, GCPs were rounded or multipolar, rather than elongated, as seen on control BG fibers, and failed to extend a leading process. Thus, formation of the migration junction between GCPs and BG fibers required glial CDH2.

![Neuron--glia attachment is dependent on glial CDH2. In vitro chimera cocultures of GCPs and BG purified from *Cdh2*^*fl/fl*^ (control) or *Cdh2*^*fl/fl*^*;hGFAP-Cre* (cKO) mice at P7. GCPs were electroporated with *Venus* (*A*, *C*, *E*, and *G*) or *Astn1-Venus* (*B*, *D*, *F*, and *H*). GCPs attached and migrated along BG fibers expressing CDH2 (*A*--*D*), irrespective of the GCP genotype. In contrast, GCPs cocultured with BG lacking *Cdh2* did not form a migration junction with the glial fibers (*E*--*H*) and had an increased separation between the GCP somas and the glial fibers (*I*). The mean distance (± SEM) between control BG fibers and control or cKO GCPs was 3.53 ± 0.42 and 3.74 ± 0.54 µm, respectively. When cKO BG were used, the mean distance (± SEM) was 11.0 ± 3.03 µm (control GCPs) and 16.8 ± 3.36 µm (cKO GCPs). Note the gap between the neuronal soma and BG fiber even as the GCP process contacts the fiber (*Inset* in *F*, arrowheads). \**P* \< 0.05; \*\**P* \< 0.01. (Scale bars: 10 µm in *A*--*H*; 5 µm in *Insets* in *B* and *F*.)](pnas.1811100115fig06){#fig06}

Taken together, our results propose a bridge model in which a *cis* complex of ASTN1 and CDH2 in the neuronal membrane interacts in *trans* with CDH2 on the glial fiber ([Fig. 7](#fig07){ref-type="fig"}) to promote glial-guided migration.

![Proposed model of the ASTN1:CDH2 *cis* and *trans* asymmetric bridge complex in the neuron--glial migration junction. Blue ovals represent the cadherin domain; yellow hexagons represent the EGF-like domain; green hexagons represent the MACPF domain; magenta ovals represent the FNIII domain; and brown ovals represent the ANX-like domain.](pnas.1811100115fig07){#fig07}

Discussion {#s9}
==========

This study reports evidence for the formation of a *cis* and *trans* asymmetric bridge complex between two families of CNS guidance receptors, CDH2 and ASTN1, as well as the discovery that CDH2 is the glial ligand for ASTN1, the neuronal receptor for glial-guided migration. These findings are supported by biochemical evidence that ASTN1 binds CDH2 in *cis*, by S2 adhesion assays showing that ASTN1 binds CDH2 in *trans*, by genetic conditional loss-of-function studies showing defects in glial-guided migration in mice lacking *Cdh2* in glia, and by in vitro chimeras showing a failure of GCPs to form a migration junction with glia lacking CDH2. Overexpression of an ASTN1 variant lacking the binding domain for CDH2 confirmed that homophilic CDH2 binding between GCPs and glia is not sufficient to support neuronal migration. Thus, heterophilic bridge complexes of ASTN1 and CDH2 are required for glial-guided neuronal migration in the developing cerebellum.

Support for *cis* interactions of ASTN1 and CDH2 was provided by immunoprecipitation assays, which further confirmed that three specific extracellular domains of ASTN1---MACPF, FNIII, and ANX-like---are required for ASTN1 binding to CDH2. This finding provided the molecular basis for studies on the overexpression of ASTN1 lacking these domains, which appeared to act as a dominant negative. The biochemical findings were also supported by S2 cell-adhesion assays showing that heterophilic ASTN1:CDH2 binding supports cell--cell adhesion in addition to homophilic CDH2-induced cell adhesion. Thus, CDH2 binds ASTN1 in both *cis* and *trans* and in intercellular adhesion. These findings are reminiscent of *cis* and *trans* binding between CDH2 and the AMPA receptor subunit GluR2 in dendritic spines ([@r32]).

Conditional loss-of-function experiments have been instrumental in defining the site of action of specific neuronal or glial receptors. The significance of glial CDH2, relative to neuronal CDH2, in glial-guided migration was evident from our finding that a glial loss of *Cdh2* resulted in dramatic effects on GCP morphology and a failure to adhere to glial fibers, whereas a neuronal loss of *Cdh2* did not affect neuron--glia binding or stall migration. We therefore propose that the binding of ASTN1 to glial CDH2 is sufficient to promote neuron--glia attachment and glial-guided migration. The finding that a loss of *Cdh2* in GCPs slowed glial-guided migration suggests that the *cis* interaction of ASTN1 and CDH2 is also important for migration, likely by stabilizing the migration junction between the neuron and the glial fiber. One mechanism for stabilizing the migration junction would be through endosomal recycling of ASTN1 back to the plasma membrane, a role that has previously been ascribed for ASTN2, the second member of the astrotactin family ([@r7]). Indeed, CDH2 has been reported to function in AMPA receptor trafficking by increasing surface expression of AMPA receptors in neurons ([@r33]).

Other studies have proposed that homophilic CDH2:CDH2 binding regulates neuron--glia attachment and migration ([@r19], [@r20]). Our bridge model does not exclude this scenario; however, the discrepancy in migration defects caused by the cell-specific loss of *Cdh2* in neurons or glia indicates that additional proteins as well as CDH2 are involved in the complex. Thus, we suggest that homophilic *trans* CDH2 interactions contribute to the formation of a migration junction but the CDH2:CDH2 complex is not sufficient for migration. The present study extends the general role for cadherins in homophilic cell--cell interactions by directly demonstrating that both *cis* and *trans* ASTN1:CDH2 interactions function in glial-guided migration.

Further support for the asymmetric bridge complex comes from the finding that a combined deletion of *Cdh2* in both GCPs and BG produced migration defects similar to the glia-specific deletion. While the combined deletion also resulted in developmental defects in the cerebral cortex, notably a double cortex ([*SI Appendix*, Fig. S2*F*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)), this was likely due to earlier expression of the *hGFAP* promoter at E13.5 ([@r29]) compared with the postnatal expression of the *mGFAP* promoter ([@r28]). Since the double-cortex phenotype indicates migration defects of cortical neurons, it is possible that the asymmetric ASTN1:CDH2 complex also regulates glial-guided migration in the cerebral cortex. However, detailed analyses will be required to address this issue. Importantly, all cerebellar migration assays in this study were comparable, as they assessed GCP migration at postnatal stages (P5--P8) where *Cdh2* was deleted in all three lines ([*SI Appendix*, Fig. S2*A*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)).

Heterophilic interactions between different cadherins have been reported ([@r34], [@r35]). However, no cerebellar defects have been described in mice with a targeted deletion of R-cadherin ([@r36]), M-cadherin ([@r37]), or cadherin-11 ([@r38]), which are expressed in the postnatal mouse cerebellum ([@r39]), suggesting that these cadherins do not function in GCP migration. Still, we cannot exclude the possibility that a partial compensation of other cadherins occurred in the neuron-specific *Cdh2* cKO. Interestingly, cadherin-11 was recently shown to regulate neural crest migration via binding of its cleaved EC1--3 domains to ErbB2 ([@r40]). Moreover, CDH2 has been demonstrated to interact in *trans* with the AMPA receptor subunit GluR2 to regulate spine formation ([@r32]). This corroborates our findings that cell adhesion and migration can be regulated by cadherins independently of homophilic or compensatory cadherin bindings.

The heterophilic ASTN1:CDH2 interaction was shown to occur via the C-terminal ectodomain of ASTN1, which included the MACPF, FNIII, and ANX-like domains ([Fig. 1*C*](#fig01){ref-type="fig"}). We were unable to pinpoint whether a single domain binds CDH2, since ASTN1 constructs lacking only the MACPF or FNIII domains failed to localize to the cell surface. Expression of ASTN1-ΔCTD in control organotypic slices did not fully stall GCP migration but significantly slowed migration, similar to the neuronal loss of *Cdh2*. Slowed GCP migration is consistent with previous migration studies in *Astn1* mutant mice ([@r13]). However, it is possible that endogenous ASTN1 might not have been fully competed out by ASTN1-ΔCTD and still might have contributed to GCP migration. In addition, we cannot exclude the possibility that other adhesion proteins are also involved in the ASTN1:CDH2 bridge complex. Nevertheless, the combined deletion of *Cdh2* with ASTN1-ΔCTD expression in GCPs resulted in a migration failure similar to that seen with glial *Cdh2* cKO, demonstrating that a *cis* interaction of ASTN1 and CDH2 in GCPs promotes migration. This is consistent with the observation that CDH2 acts in combination with nectin-based adhesion to regulate radial glia-independent somal translocation ([@r41]).

Although the intracellular aspect of ASTN1 does not contain any domains known to be involved in intracellular signaling pathways, it is possible that the complex of ASTN1:CDH2 functions in intracellular signaling during migration. The best-characterized signaling cascades involving CDH2 are β-catenin ([@r42]) and GTPases ([@r22], [@r43]). While recent studies support a key role for Rho, Rab, and Rap GTPases in the control of CDH2 function ([@r18], [@r22], [@r43]) and in GCP migration via actin-regulatory pathways ([@r10]), their signaling role in CDH2:ASTN1 complexes remains to be determined. In addition, since prior EM studies revealed the presence of microfilaments in the migration junction ([@r6]) where ASTN1 localizes ([@r11]), it will be important to assay the involvement of β-catenin and cytoskeletal elements, including actin-binding proteins, in the migration junction.

Our study provides a direct demonstration of *cis* and *trans* interactions of CDH2 with a CNS migration receptor and raises the possibility for a general function for heterophilic cadherin--receptor complexes in the formation of a wide range of cell--cell junctions.

Materials and Methods {#s10}
=====================

Animals. {#s11}
--------

B6.129S6(SJL) *Cdh2*^*fl/fl*^ mice (backcrossed to C57BL/6) carrying loxP sites flanking exon 1 of the *Cdh2* gene (stock no. 007611; Jackson Laboratory) were crossed with *Tg(NeuroD1-Cre) RZ24*, *Tg(hGFAP-Cre) PK90*, or *Tg(mGFAP-Cre)* lines. *Cdh2*^*fl/+*^*;NeuroD1-Cre*, *Cdh2*^*fl/+*^*;mGFAP-Cre*, and *Cdh2*^*fl/+*^*;hGFAP-Cre* progeny were crossed with *Cdh2*^*fl/fl*^ mice to generate *Cdh2*^*fl/fl*^*;Cre*^*+/−*^ experimental mice and *Cre*-negative *Cdh2*^*fl/fl*^ control littermates. Genotyping details are described in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental). All procedures were performed according to guidelines approved by the Rockefeller University Institutional Animal Care and Use Committee.

DNA Constructs. {#s12}
---------------

See [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental) for details.

GC/BG Cocultures. {#s13}
-----------------

Cocultures of GCPs and BG from P7 cerebella were prepared as described previously ([@r30]). Briefly, a dissociated cerebellar cell suspension was applied to a two-step gradient of 35%/60% Percoll (Sigma-Aldrich) in Tyrode's solution and was centrifuged at 2,000 × *g* for 10 min at 4 °C. The large cell fraction at the Tyrode's solution/35% Percoll interface (BG) and the small cell fraction at the 35%/60% Percoll interface (GCPs) were subsequently washed and preplated in GC medium ([*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)) on untreated Petri dishes at 35 °C/5% CO~2~ for 20 min to remove fibroblasts. The BG fraction was thereafter cultured on 0.1 mg/mL poly-[d]{.smallcaps}-lysine--precoated 12-mm coverslips for 1 h at 35 °C/5% CO~2~. The unbound cell suspension was then removed, and the adhering glial cells were cultured in GC medium at 35 °C/5% CO~2~. The GCP fraction was transferred to a 60-mm tissue-culture dish and incubated for 30 min at 35 °C/5% CO~2~. The dish was then tapped to dislodge the GCPs. The cell suspension was transferred to a new tissue-culture dish, and the process was repeated for maximal purification of GCPs. Purified GCPs were then electroporated with an Amaxa Mouse Neuron Nucleofection kit (Lonza) as described in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental). GCPs were added to the BG cultures at a GCP:BG ratio of 5:1. The cocultures were incubated at 35 °C/5% CO~2~ for 48--72 h.

Organotypic Slice Cultures. {#s14}
---------------------------

The method is described in previous work ([@r10]) and detailed in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental). Briefly, P8 cerebella from *Cdh2*^*fl/fl*^ and *Cdh2*-cKO littermates were dissected out and electroporated with *pCIG2-Venus* (0.5 µg/µL), *pCIG2-Astn1-FL-Venus* (1 µg/µL), or *pCIG2-Astn1-ΔCTD-Venus* (1 µg/µL) plasmids dorsal-to-ventral for 50 ms at 80 V, for a total of five pulses with an interval of 500 ms between pulses, using an ECM 830 Electro Square Porator (BTX Genetronics). The cerebella were then embedded in 3% agarose in HBSS, and 250-µm horizontal slices were made using a Leica VT1000S vibratome. Slices were placed on Millicell-CM 0.4-µm culture plate inserts (Millipore) and cultured for 60 h at 35 °C/5% CO~2~.

Immunohistochemistry/Cytochemistry. {#s15}
-----------------------------------

Brains were dissected out and fixed in 4% paraformaldehyde in PBS at 4 °C overnight and thereafter were cryoprotected in 20% sucrose in PBS at 4 °C overnight. Sagittal cryosections (25 µm), organotypic slice cultures, or GCP/BG cocultures were processed for immunohistochemistry as described in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental).

BrdU Labeling. {#s16}
--------------

BrdU in PBS (BD Biosciences) (50 µg/g of body weight) was injected s.c. in the neck of P5 *Cdh2*^*fl/fl*^ and *Cdh2*-cKO littermates. The brains were dissected out 48 h later and processed for immunohistochemistry as described in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental).

Immunoprecipitation and Western Blotting. {#s17}
-----------------------------------------

Briefly, transfected HEK 293T cells (clone 17; ATCC CRL-11268) or whole cerebella were extracted in ice-cold lysis buffer ([*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental)) and precleared with 25 µL Protein G/A Agarose beads (Calbiochem). The lysates were incubated with 3 µg of a rabbit GFP antibody (Invitrogen), rabbit Astn1 antibody ([@r12]), or normal rabbit IgG (Santa Cruz Biotechnology) for 2 h at 4 °C. Immunoprecipitates were collected on 50 µL Protein G/A Agarose beads by overnight rotation at 4 °C, washed with lysis buffer, and resuspended in 50 µL 2× Laemmli buffer. Western blotting was performed as described in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental).

S2 Cell-Adhesion Assay. {#s18}
-----------------------

*Drosophila* S2 cells (Life Technologies) were transfected for 24 h as described in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental), and 1.5 × 10^6^ cells from each condition were mixed together at a density of 3 × 10^6^ cells per well (1 × 10^6^ cells/mL) and shaken gently at 28 °C for up to 2 h to allow aggregation. Cells were imaged immediately after the conditions were set up (*t* = 0) and after 30 min, 1 h, and 2 h. For full details, see [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental).

Flow Cytometry. {#s19}
---------------

Transfected HEK 293T cells were harvested in 1 mM EDTA in PBS. The surface fraction of Venus-linked ASTN1 variants was labeled with rabbit anti-GFP (1:5,000; Invitrogen) for 20 min at 4 °C followed by Alexa Fluor 647 donkey anti-rabbit (1:5,000; Life Technologies) for 25 min at 4 °C. Flow cytometry analysis was carried out on a BD Accuri C6 flow cytometer system (BD Biosciences) using 488-nm and 640-nm lasers as described in [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental).

Statistical Analyses. {#s20}
---------------------

See [*SI Appendix*](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental) for details. Differences between conditions were determined using unpaired *t* tests for equal or unequal variances, except for migration distance in the slice cultures where Kruskal--Wallis and Mann--Whitney *U* nonparametric tests were used. Significance was set at *P* \< 0.05 (two-sided). In the bar diagrams, data are presented as means; error bars represent SDs in [Figs. 2](#fig02){ref-type="fig"}, [3](#fig03){ref-type="fig"}, and [5*H*](#fig05){ref-type="fig"} and [*SI Appendix*, Fig. S4](http://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1811100115/-/DCSupplemental) and SEM in [Fig. 6](#fig06){ref-type="fig"}. The migration distance data from the slice cultures are presented in box plots ([Figs. 4](#fig04){ref-type="fig"} and [5*G*](#fig05){ref-type="fig"}).
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